Grupo Cantabria Labs

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• DIETARYLBL1 refused line

  Not identified as a dietary supplement

  The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).

• LABELING1 refused line

  Fair Packaging and Labeling Act

  The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.

• NO ENGLISH1 refused line

  Required label information not in English

  Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

• NOT LISTED1 refused line

  Product not listed with FDA

  The product appeared to be a drug or device that is not included in the listing FDA requires under section 510(j) of the FD&C Act.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Grupo Cantabria Labs

Is Grupo Cantabria Labs on an FDA import alert?

No listing for Grupo Cantabria Labs appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Spain page.

Has FDA refused shipments from Grupo Cantabria Labs?

Yes. FDA refused 2 shipment lines from Grupo Cantabria Labs between January 22, 2025 and June 2, 2026. The most recent, on June 2, 2026, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as DIETARYLBL (not identified as a dietary supplement).

Why did FDA refuse Grupo Cantabria Labs's shipments?

The most frequent charges are DIETARYLBL (not identified as a dietary supplement, 1 line) and LABELING (fair packaging and labeling act, 1 line).

What is Grupo Cantabria Labs's FEI number?

Grupo Cantabria Labs's FDA Establishment Identifier (FEI) is 3022985641.